Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...
Chris Johnson, MBA, explains how retail-based pediatric clinics and smart tech can expand Medicaid access and streamline ...
At the IVBM Charlotte event, Seungjean Chai, MD, emphasized that patient-centered design, guidelines, and subspecialty expertise are essential to high-value oncology care.
At the IVBM Charlotte event, Seungjean Chai, MD, emphasized that patient-centered design, guidelines, and subspecialty ...
Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD, discuss the clinical value of the uACR test and why it remains underutilized. Chronic kidney disease (CKD) affects an estimated 37 million ...
Only Iowa, Montana, and Nebraska plan pre-2027 implementation with disenrollment; Arkansas anticipates a July soft launch ...
Real-world, peer-to-peer discussions on how health systems implement, operationalize, and scale population health programs.
In the US, the highest rates of colorectal cancer are found in those of American Indian, Alaska Native, and African American ...
Existing care management approaches, such as Principal Care Management (PCM), Transitional Care Management (TCM), and ...
As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case ...
Diagnosed with childhood alopecia, she navigates patchy hair loss, limited rural care, stigma, and uncertainty—until ...
Oncology pharmacists can operationalize payer-mediated transitions such as biosimilar adoption, minimizing clinician burden while reducing waste and total cost of care. Earlier CAR T-cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results